Abstract Body

Background

Despite antiretroviral therapy (ART) initiation during acute HIV infection (AHI), persistent immune alterations remain. To better understand the deviation from immune homeostasis, we performed longitudinal phenotypic and transcriptional profiling of peripheral blood mononuclear cells (PBMCs) from early-treated people living with HIV (PLWH) using HIV uninfected controls as reference population.

Methods

Matched PBMC samples were analyzed during AHI (T0, n=36) and after one year of stable viral suppression (UD+1, n=26). PBMC from HIV-uninfected individuals (HCs, n=21) were included as controls. Flow cytometry (26-color) data were clustered using FlowSOM. Cellular indexing of transcriptomes and epitopes (CITE-seq) was performed for T0 (n=7), UD+1 (n=7), and HCs (n=7). Cells were clustered with unsupervised weighted-nearest neighbor (WNN) analysis integrating RNA and protein features to define immune cell states. Differential gene expression, pathway analysis and MultiNicheNet analysis were performed on the different cellular clusters.

Results

Flow cytometry identified 30 metaclusters of CD4 and CD8 T cells, γδ T cells, MAIT cells, NK cells, B cells, and monocytes. AHI was associated with marked shifts in cellular composition and activation that largely normalized after one year of ART. However, CD8 T cell perturbations persisted, with elevated activation and expansion of CD8 TEMRA cells despite viral suppression. In addition, monocyte frequencies were reduced during AHI and failed to normalize with ART. CITE-seq analysis identified 28 distinct clusters and showed that at UD+1 classical CD14+ monocytes were transcriptionally the most divergent subset compared to HCs. Differential gene expression and pathway analysis revealed enrichment of NF-κB- and IFNγ-driven programs in CD14+ monocytes (Fig.1A). A prominent role for the CD14 monocytes in the immune cell signaling network at UD+1 was supported by MultiNicheNet analysis (Fig. 1B) showing intensified intercellular signaling from this subset to multiple immune cell types.

Conclusions

Even with ART initiation during AHI, monocyte activation remains aberrant in virally suppressed people living with HIV. These findings highlight monocytes as a potential driver of residual immune dysfunction and suggest they may represent a therapeutic target to mitigate long-term immune activation.

Table or Figure